Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular Checkpoint Decisions Made by Subverted Vascular Niche Transform Indolent Tumor Cells into Chemoresistant Cancer Stem Cells

Published:2017-01 Issue:1 Volume:31 Page:110-126
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Cao Zhongwei,Scandura Joseph M.,Inghirami Giorgio G.,Shido Koji,Ding Bi-Sen,Rafii Shahin

Funder

New York Stem Cell Foundation

Ansary Stem Cell Institute

Taub Foundation Grants

Tri-Institutional Stem Cell Initiative

Leukemia & Lymphoma Society

Empire State Stem Cell Board

New York State Department of Health

ECRIP

NIH

Italian Association for Cancer Research

SCOR Leukemia Lymphoma Society Grant

starr foundation

American Heart Association

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference53 articles.

1. A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours;Beck;Nature,2011

2. Modes of resistance to anti-angiogenic therapy;Bergers;Nat. Rev. Cancer,2008

3. Human IgG1 antibodies suppress angiogenesis in a target-independent manner;Bogdanovich;Signal. Transduct. Target. Ther.,2016

4. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties;Bono;Cancer Cell,2013

5. A perivascular niche for brain tumor stem cells;Calabrese;Cancer Cell,2007

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. References;The Evolution of Immunotherapy Against Tumors;2025

2. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis;Drug Resistance Updates;2024-09

3. Targeting the tumour vasculature: from vessel destruction to promotion;Nature Reviews Cancer;2024-08-29

4. Targeting CD25+ lymphoma cells with the antibody–drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agents;British Journal of Haematology;2024-07-30

5. A review concerning the breast cancer-related tumour microenvironment;Critical Reviews in Oncology/Hematology;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3